- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07605650
Effect of Adding Thoracolumbar Fascia Release by IASTM to Conventional Treatment on Craniovertebral Angle in Forward Head Subjects (IASTM)
Influence of Thoracolumbar Fascial Release by Instrument Assisted Soft Tissue Moblization on Craniovertebral Angle in Forward Head Posture
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The FHP is expected to have a major impact on respiratory function by weakening the accessory respiratory muscles. Persistent FHP weakens the muscles involved in breathing, leading to a decline in respiratory function. Also, it was suggested that FHP is quite common in undergraduate students and has significant effect on level of stress.
A vital component of the myofascial girdle envelops the lower torso, thoracolumbar fascia, participates in posture, load transfer, and breathing. The deep muscles at the back of the spine and the muscles in the abdomen are covered by the TLF. The latissimus dorsi, gluteus maximus, and other muscles in the area are related to a few muscles that engage in the movement of the proximal limbs, and the TLF functions as a force-transmitting structure.
When the upper extremities are impacted, the thoracolumbar fascia release (TLFR) technique should be considered, however, there has not been much research that uses TLFR for the upper extremities. The TLF works together by connecting with the deep core muscles. The medium and posterior parts of the TLF form the transversus abdominis, and the deep lamina is associated with the lumbar spinous processes .
The deep posterior layer continues cranially by merging with the splenius cervicis fascia. Therefore, TLF plays a role in Cervical region mobility. The TLFR increased bilateral sternocleidomastoid muscle resistance and decreased head-forward posture angle in the short term in young women with head-forward posture .
Another novel technique that is quickly gaining traction is IASTM, which allows physicians to treat patients with soft tissue dysfunction in a non-invasive manner. By remodeling connective tissue, resorbing excess fibrosis, recruiting fibroblasts, and inducing collagen repair and regeneration, IASTM mobilizes connective tissue and myofascial adhesions using specially designed instruments. The use of IASTM is recommended to improve the range of motions in healthy individuals, reduce pain in patients with musculoskeletal injuries.
However, there is a gap of empirical data establishing the effect of adding TLF release by IASTM to conventional treatment protocol of FHP on CVA, Cervical ROM, Cervical proprioception and stress level.
Therefore, this study sought to determine the effect of adding TLFR to conventional treatment protocol of FHP to improve CVA, Cervical ROM, Cervical proprioception and stress level.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Mariam M Abdallah, Assistant lecturer
- Numéro de téléphone: +201221337723
- E-mail: mariam.youssef@cu.edu.eg
Sauvegarde des contacts de l'étude
- Nom: Aya M Mohamed, Lecturer
- Numéro de téléphone: +201066925459
- E-mail: aya_mahmoud_mohamed@cu.edu.eg
Lieux d'étude
-
-
Giza Governorate
-
Giza, Giza Governorate, Egypte, 12611
- Recrutement
- Faculty of Physical Therapy
-
Chercheur principal:
- Ragia M kamel, professor
-
Sous-enquêteur:
- Mary K Nassif, Assistant professor
-
Sous-enquêteur:
- Aya M Mohamed, lecturer
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Forward head posture subjects with CVA of < 52
- Subject's age ranged from 18-30 years old, with Body Mass Index (BMI) less than 30Kg/m2.
Pain-free subjects for over 3 months, No PT intervention. Exclusion Criteria;
- Osteoporotic disorder.
- Any history of congenital deformities of the Cervical and Thoracic region.
- Recent injuries or fractures.
- Any inflammatory joint disorder.
- Malignancy.
- Vascular disorders.
- Neurological or psychiatric disorders.
- Any respiratory disease, presence of open wound/s, or history of surgery in the past 6 months.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Autre: control group
Control group (conventional treatment protocol): The control group will receive firstly, Kendall exercises; every strengthening exercise will be repeated for 12 repetitions and done for 3 sets and each stretching exercise will be held for 30 seconds and repeated 3 times. Then, participants will receive IASTM application on cervical muscles as follows: IASTM for upper fibers of trapezius, levator scapulae muscles and scalnae. |
Instrument-assisted soft tissue mobilization (IASTM) is a special instrument with beveled edges to assist the clinician in the evaluation and mobilization of soft tissue.
Instruments are used in a multi directional stroking fashion applied to the skin at 30°-60° angles to detect soft tissue irregularities via the undulation of the tools.
It has been purported to enhance proliferation of extracellular matrix fibro blasts, improve ion transport, and decrease cell matrix adhesions
Autres noms:
|
|
Expérimental: experimental group
participants will receive same protocol as control group (IASTM on cervical muscles and Kendel exercises) in addition to Thoraco lumber fascia release using IASTM tool
|
Instrument-assisted soft tissue mobilization (IASTM) is a special instrument with beveled edges to assist the clinician in the evaluation and mobilization of soft tissue.
Instruments are used in a multi directional stroking fashion applied to the skin at 30°-60° angles to detect soft tissue irregularities via the undulation of the tools.
It has been purported to enhance proliferation of extracellular matrix fibro blasts, improve ion transport, and decrease cell matrix adhesions
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Craniovertebral angle(CVA)
Délai: measurement at Day 1 then after 1 month
|
Craniovertebral angle (CVA) is a line drawn from the tragus of the ear to the C7 vertebra intersects a horizontal line.
It is used to measure the value of FHP, and the greater the value of this angle, the more forward the head is positioned on the neck.
A vast variety of names exist for this angle, such as sagittal C7-tragus angle, sagittal plane head alignment, neck inclination angle, Cervical angle, head protrusion angle, head position, FHP, forward head position, and head anteriorization in relation to Cervical vertebra
|
measurement at Day 1 then after 1 month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
cervical range of motion
Délai: measurement at Day 1 then after 1 month
|
flexion ,extension,sidebending ,rotation
|
measurement at Day 1 then after 1 month
|
|
cervical proprioception
Délai: measurement at Day 1 then after 1 month
|
flexion, extension,sidebending,rotation
|
measurement at Day 1 then after 1 month
|
|
Cohen perceived stress scale
Délai: measurement at Day 1 then after 1 month
|
Arabic version for stress scale
|
measurement at Day 1 then after 1 month
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- Faculty of Physical Therapy CU
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .